Cardiology

Outcomes-based pricing doesn't cut costs of PCSK9 inhibitors

(HealthDay)—Outcomes-based pricing does not reduce the costs of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, according to a research letter published online April 3 in the Annals of Internal Medicine.

Cardiology

New ACC/AHA recs developed for BP evaluation, management

(HealthDay)—New recommendations have been developed for the prevention, detection, evaluation, and management of high blood pressure (BP). The recommendations are summarized in an article published online Jan. 23 in the ...

Cardiology

High-risk plaque on coronary CTA linked to future MACE

(HealthDay)—For outpatients with stable chest pain, high-risk plaque found by coronary computed tomographic angiography (CTA) is associated with subsequent major adverse cardiovascular events (MACE), according to a study ...

Cardiology

Heart failure risk factors need a closer look

Assessing the risk of heart attack and stroke is a common practice among doctors and their patients; however, the risk factors for heart failure are not as clearly laid out or considered. A group of Baylor College of Medicine ...

page 6 from 10